Log in to save to my catalogue

PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumor...

PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumor...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4249650

PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors

About this item

Full title

PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors

Publisher

New York: Nature Publishing Group US

Journal title

Nature genetics, 2014-11, Vol.46 (11), p.1227-1232

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Ping Chi and colleagues identify recurrent inactivating mutations in the PRC2 core components
EED
and
SUZ12
in malignant peripheral nerve sheath tumors. They further show that PRC2 loss is associated with loss of H3K27 trimethylation and aberrant expression of PRC2 target genes and downstream pathways.
Malignant peripheral nerve shea...

Alternative Titles

Full title

PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4249650

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4249650

Other Identifiers

ISSN

1061-4036

E-ISSN

1546-1718

DOI

10.1038/ng.3095

How to access this item